Phase II/III (Integrated)

401 trials 182 recruiting

Filter these 401 trials by condition, country, sponsor and more.

Open in Search →

Study of hydroxocobalamin at a new concentration for cobalamin-related remethylation disorders. Pending

2024-516862-12-00 Hydroxycobalamin deficiency
A phase 2 trial of capecitabine for recurrent and/or metastatic salivary duct carcinoma – CAESAR trial Pending

2024-516956-16-01 Salivary Duct Carcinoma
Evaluation of Botulinum TOXin type A in the treatment of Buerger’s disease Pending

2024-517772-38-00 Buerger's disease
An open-label phase 2/3 study to analyse the feasibility and evaluate the safety of intravenous administration of 99mTc-PSMA-T4 in patients … Pending

2024-519358-35-00 Feasibility analysis and safety evaluation of [99mTc]Tc
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH). Pending

2024-520218-23-00 Pulmonary Arterial Hypertension
A study of BMN 333 versus Vosoritide in Children with Achondroplasia Pending

2025-523811-12-00 Achondroplasia
An experimental trial to learn about hu14.18K322A treatment in children and adolescents with high-risk neuroblastoma. Pending

2025-524397-42-00 Participants with relapsed HRNB and participants with
The GranStone Trial Pending

2026-525608-85-00 Paraffin Oil Induced Granulomatous Disease
Changes in plaque characteristics after short-term statin therapy assessed with coronary CT (INTENSE) Pending

2025-522868-32-00 Coronary Artery Disease
The Surf trial Pending

2025-523898-42-00 Histologically confirmed solid malignancy (e.g., head a
A randomized double-masked, multicenter, 3 arm pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8… Recruiting

2025-524575-22-00 Neovascular age-related macular degeneration (NVAMD) 2026-06-30
A Study of Treatments for the Prevention of Disease Progression in Individuals at Risk for or With Early Onset Alzheimer’s Disease Caused by… Recruiting

2024-517187-36-01 Dominantly Inherited Alzheimer’s Disease (DIAD) 2026-06-24
A clinical trial of MK-1045 in people with B-cell acute lymphoblastic leukemia Recruiting

2025-522267-15-00 Relapsed/refractory B-cell Acute Lymphoblastic Leukemi 2026-06-24
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003) Recruiting

2025-524894-17-00 Neovascular age-related macular degeneration (NVAMD) 2026-06-22
A clinical trial of MK-1045 and rituximab in people with follicular lymphoma (MK-1045-007) Recruiting

2025-522777-10-00 Follicular Lymphoma 2026-06-19
Phase II/III randomized controlled open-label trial to evaluate the efficacy and safety of personalized tissue engineered veins in patients … Recruiting

2025-524103-69-00 Chronic Venous Insufficiency 2026-06-10
A Study to Learn about the Study Medicine called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive Stage Sma… Recruiting

2025-523522-41-00 Extensive-Stage Small Cell Lung Cancer 2026-06-01
Ublituximab in Pediatric Participants with Relapsing forms of Multiple Sclerosis (RMS) Recruiting

2025-522257-19-00 Relapsing Multiple Sclerosis 2026-05-12
A Clinical Trial to Compare the Effectiveness and Safety of RO7771950 in Combination with Trastuzumab and Capecitabine, Versus Tucatinib in … Recruiting

2025-524498-17-00 Pretreated Unresectable Locally Advanced or Metastatic 2026-05-08
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients with Colorectal, Gastric, … Recruiting

2024-519384-18-00 Colorectal, Gastric, Ovarian or Pancreatic Cancer 2026-04-29
A study to investigate the efficacy and safety of frexalimab versus tacrolimus in adults undergoing kidney transplantation Recruiting

2025-521521-33-00 Kidney transplant rejection 2026-04-02
A Study in Pediatric Participants with Congenital Adrenal Hyperplasia Recruiting

2024-519578-38-00 Classic congenital adrenal hyperplasia 2026-03-30
A study to learn if DM199 drug is safe and whether it works better than placebo for treating acute ischemic stroke Recruiting

2024-513911-28-00 Acute Ischemic Stroke 2026-03-04
A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy. Recruiting

2025-522553-19-00 Symptomatic genetic and familial dilated cardiomyopathy 2026-02-25